TG Therapeutics Inc (TGTX) — Capital Reinvestment Ratio

Latest as of June 2025: 0.01x

TG Therapeutics Inc (TGTX) has a Capital Reinvestment Ratio of 0.01x as of June 2025, meaning it reinvests 0% of its operating cash flow ($7.44 Million) in capital expenditures ($42.00K). See TG Therapeutics Inc (TGTX) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$7.44 Million

USD

Capital Expenditures

$42.00K

USD

Data as of

Jun 2025

Most recent filing

Annual Capital Reinvestment Ratio for TG Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for TG Therapeutics Inc from None to None. For live market cap and broader valuation context, see TGTX market cap.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow